Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease
The twice-weekly rivastigmine patch offers a convenient and straightforward dosing regimen for caregivers, with potential to enhance adherence with treatment in AD patients without causing serious adverse events.
Authors
- Rosario Carrillejo
- Miguel Ángel Barbancho (ORCID: https://orcid.org/0000-0001-9120-4831)
- Teresa Rodríguez del Rey (ORCID: https://orcid.org/0000-0001-5536-1848)
- José Miguel García-Castro
- Raquel López-García
- Rosa López-Mongil (ORCID: https://orcid.org/0000-0003-0548-2582)
- Maria E. Leon (ORCID: https://orcid.org/0000-0001-8167-408X)
- Esther Gris
- Francisca Ríus (ORCID: https://orcid.org/0000-0001-8108-5031)
- Paz de la Guía
- José María García‐Alberca (ORCID: https://orcid.org/0000-0003-2951-6644)
- Merçé Boada (ORCID: https://orcid.org/0000-0003-2617-3009)
- Teresa García-López
- Xavier Morató (ORCID: https://orcid.org/0000-0002-3012-2864)
- Encarnación Blanco‐Reina (ORCID: https://orcid.org/0000-0001-5892-5450)
- José Manuel Marín-Carmona
- José Antonio López-Trigo (ORCID: https://orcid.org/0000-0002-5327-6583)
- José Pablo Lara (ORCID: https://orcid.org/0000-0002-2015-7385)
- María López de la Rica
- Nyole Gabriunas de Páez
- Silvia Mendoza
- Javier Gay-Puente (ORCID: https://orcid.org/0000-0002-6157-1726)
- Federico Casales
- Gemma González-Velasco
Institutions
- Instituto de Neurociencias (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital El Bierzo (ES)
- Fundació ACE (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1177/13872877241292018
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Esteve Pharmaceuticals